Guleryuz Partners has advised Haver Farma Ilac on its full acquisition of MS Pharma SARL’s Turkish subsidiary, MS Pharma Ilac. PwC Legal reportedly advised the seller.
Haver Farma provides services and products to public and private hospitals in the health sector. Its portfolio includes products used in oncology, cardiology, general surgery, internal medicine, and other therapeutic areas, as well as vitamins and supplements.
MS Pharma is a multinational pharmaceutical company headquartered in Amman, Jordan, with its management office in Switzerland. It specializes in the development, production, and distribution of generic and specialty medicines.
Guleryuz Partners’ team was led by Partner Zahide Altunbas Sancak.
